top of page
  • LinkedIn

Every trial has a
clinical protocol.

Few have a human one.

The Human Protocol

PRO
Transparent 2.png

THE BLIND SPOT

Except for the people.

85%

of clinical trials experience delays, with patient recruitment as the #1 cause.

of all trials take longer than planned to enroll.

$800K+

per day in lost revenue from trial delays.

THE MISSING SYSTEM

THE MISSING SYSTEM

Every clinical trial runs on three systems.

Only two are intentionally designed.

01

Scientific System

Designed. Reviewed. Redesigned.

02

Operational System

Managed. Monitored. Audited.

03

Participation System

Assumed. Almost never designed.

CLINVANA engineers the participation system.

No New Passwords
CLINVANA AI Technology

NO NEW PASSWORDS

We're not anti-tech.

We're anti-autopilot.

Human intelligence that makes your tech investments work.

We use AI deliberately in strategy, creative, and measurement.

Senior people govern every input and output.

We don't add platforms.

We add the layer that makes yours worth opening.

No new logins. No new dashboards.

Just better signal from the data you already have.

MOA
CLINVANA Site Staff

MECHANISM OF ACTION

Enrollment is a consequence,
not a campaign.

Enrollment

Experience

Evidence

We activate it.

Study brand. Physician activation. Patient campaigns. Referral pathway design. Pre-screening communications built for the people making the decision – not the study asking for it.

We sustain it.

Consent orientation. Visit communications. Coordinator enablement. Burden mapping. Engagement across the full participation arc – anticipating the moments where trials lose people before they happen.

We quantify it.

The metrics your team already tracks, read through the human layer. Where experience is moving enrollment. Where friction is costing time. What to do about it.

CLINVANA PAH Patient Recruitment
RWE

CASE IN POINT

Patients / site / month: 0.3 → 0.9

In eleven weeks. Without adding a single site.

SF%

82% → 59%

Screen Fail Rate Reduction

R90

61% → 88%

Retention Rate @ 90 Days

CV

38%

Coefficient of Variation -
Site Performance

εSR

40%

Epsilon Site Rate

Phase 2 – Pulmonary Arterial Hypertension (PAH) · 12 sites across North America

THE EVIDENCE LAYER

THE EVIDENCE LAYER

Your data has been trying to
tell you something.

We built the framework that actually listens.

THE ENROLLMENT EQUATION

E = R ∙ T ∙ S + N

Enrollment · Rate · Time · Sites · Already enrolled

E = Σ(Rᵢ × T) + N

Because every site has its own rate

σ = √[1/S × Σ(Pᵢ − P̄)²]

Standard deviation of site performance

CV = σ / P̄

Coefficient of Variation, Site Performance

THE FIVE LENSES

P | S | M

Patients per Site per Month ·

Site productivity and referral pathway health

SF %

Screen Failure Rate ·

Referral quality and patient preparation

R90

Retention at 90 Days ·

Patient experience and comprehension proxy

FPS

Time to First Patient Screened · Site readiness signal

εSR

Epsilon Site Rate · Post-activation human friction detection

These aren't just metrics.
They're participation system diagnostics.

BASELINE

CV = σ / P̄

POST-INTERVENTION
CLINVANA CV matrix baseline
CLINVANA CV matrix post intervention
KOL
Matthew Kibby

"

Everyone's solving for speed.

We're
solving for trust –

because trust is actually your fastest path to enrollment, retention, and clean data.

We just made it measurable.

- Matt Kibby, Founder & CEO, CLINVANA

Let's build your human protocol.

Together.

CONNECT

CONNECT

You found us.

You made it this far for a reason.

The participation system you've been missing is one conversation away.

+1 617-686-1221 

bottom of page